These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20379036)

  • 21. Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta.
    Kumar A; Klinge CM; Goldstein RE
    Int J Oncol; 2010 May; 36(5):1067-80. PubMed ID: 20372779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
    Bowers JL; Tyulmenkov VV; Jernigan SC; Klinge CM
    Endocrinology; 2000 Oct; 141(10):3657-67. PubMed ID: 11014220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
    Marsaud V; Gougelet A; Maillard S; Renoir JM
    Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogenic and antiestrogenic activities of anordiol: a comparison of uterine and vaginal responses with those of clomiphene citrate.
    Peters AJ; Wentz AC; Kazer RR; Jeyendran RS; Chatterton RT
    Contraception; 1995 Sep; 52(3):195-202. PubMed ID: 7587192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A distal estrogen responsive element upstream the cap site of human transthyretin gene is an enhancer-like element upon ERα and/or ERβ transactivation.
    Martinho A; Santos CR; Gonçalves I
    Gene; 2013 Sep; 527(2):469-76. PubMed ID: 23860318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nebivolol decreases endothelial cell stiffness via the estrogen receptor beta: a nano-imaging study.
    Hillebrand U; Lang D; Telgmann RG; Hagedorn C; Reuter S; Kliche K; Stock CM; Oberleithner H; Pavenstädt H; Büssemaker E; Hausberg M
    J Hypertens; 2009 Mar; 27(3):517-26. PubMed ID: 19330906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional activity of estrogen receptors ERalpha and ERbeta in the EtC.1 cerebellar granule cell line.
    Gottfried-Blackmore A; Croft G; McEwen BS; Bulloch K
    Brain Res; 2007 Dec; 1186():41-7. PubMed ID: 18021758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements.
    Klinge CM; Bowers JL; Kulakosky PC; Kamboj KK; Swanson HI
    Mol Cell Endocrinol; 1999 Nov; 157(1-2):105-19. PubMed ID: 10619402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro effects of clomiphene citrate on human endometrium.
    Markiewicz L; Laufer N; Gurpide E
    Fertil Steril; 1988 Nov; 50(5):772-6. PubMed ID: 3181488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of estrogen receptor alpha- and beta-selective substances in the metaphysis of the tibia and on serum parameters of bone and fat tissue metabolism of ovariectomized rats.
    Seidlová-Wuttke D; Prelle K; Fritzemeier KH; Wuttke W
    Bone; 2008 Nov; 43(5):849-55. PubMed ID: 18708178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.
    Kuiper GG; Lemmen JG; Carlsson B; Corton JC; Safe SH; van der Saag PT; van der Burg B; Gustafsson JA
    Endocrinology; 1998 Oct; 139(10):4252-63. PubMed ID: 9751507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of benzo[a]pyrene and its hydroxylated metabolites in an estrogen receptor-alpha reporter gene assay.
    Charles GD; Bartels MJ; Zacharewski TR; Gollapudi BB; Freshour NL; Carney EW
    Toxicol Sci; 2000 Jun; 55(2):320-6. PubMed ID: 10828263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of coregulators influenced by estrogen receptor subtype specific binding of the ER antagonists 4-hydroxytamoxifen and fulvestrant.
    Evers NM; Wang S; van den Berg JH; Houtman R; Melchers D; de Haan LH; Ederveen AG; Groten JP; Rietjens IM
    Chem Biol Interact; 2014 Sep; 220():222-30. PubMed ID: 25014417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracellular signaling involved in estrogen regulation of serotonin reuptake.
    Koldzic-Zivanovic N; Seitz PK; Watson CS; Cunningham KA; Thomas ML
    Mol Cell Endocrinol; 2004 Oct; 226(1-2):33-42. PubMed ID: 15489003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen and estrogen receptor antagonists stimulate transcription from the human retinoic acid receptor-alpha 1 promoter via a novel sequence.
    Elgort MG; Zou A; Marschke KB; Allegretto EA
    Mol Endocrinol; 1996 May; 10(5):477-87. PubMed ID: 8732679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
    Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B
    Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure activity relationships and differential interactions and functional activity of various equine estrogens mediated via estrogen receptors (ERs) ERalpha and ERbeta.
    Bhavnani BR; Tam SP; Lu X
    Endocrinology; 2008 Oct; 149(10):4857-70. PubMed ID: 18599548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subtype-specific activation of estrogen receptors by a special extract of Rheum rhaponticum (ERr 731), its aglycones and structurally related compounds in U2OS human osteosarcoma cells.
    Möller F; Zierau O; Jandausch A; Rettenberger R; Kaszkin-Bettag M; Vollmer G
    Phytomedicine; 2007 Nov; 14(11):716-26. PubMed ID: 17935960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: Insights into the structural determinants favoring a differential subtype binding.
    Zhu BT; Han GZ; Shim JY; Wen Y; Jiang XR
    Endocrinology; 2006 Sep; 147(9):4132-50. PubMed ID: 16728493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential interactions of bisphenol A and 17beta-estradiol with estrogen receptor alpha (ERalpha) and ERbeta.
    Hiroi H; Tsutsumi O; Momoeda M; Takai Y; Osuga Y; Taketani Y
    Endocr J; 1999 Dec; 46(6):773-8. PubMed ID: 10724352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.